Report shows U.S. cancer deaths on the decline
the ONA take:
According to a new report published in the Journal of the National Cancer Institute, there has been a continuing decline in cancer deaths in the United States between 2002 and 2011. During that period, the overall cancer death rate fell an average 1.5% per year for men, women, and children. Specifically, cancer death decreased 1.8% per year among men, 1.4% per year among women, and about 2% per year for children.
The report also found that the rate of new cancer cases also decreased an average 0.5% per year during those years. However, the report found that cancer rates are increasing for kidney, liver, mouth and throat, and thyroid cancer.
"These numbers reflect a combination of factors that include prevention, early detection and improved treatment," said report co-author Ahmedin Jemal, vice president of surveillance research for the American Cancer Society.
Colon and breast cancer deaths are declining due to prevention efforts, while lower rates of lung cancer deaths are due to fewer people smoking. Prostate cancer rates are also declining, but experts are not sure why.
There has been a continuing decline in cancer deaths in the United States between 2002 and 2011.
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Whole Genome Sequencing Reveals that 12% of Childhood Cancer Survivors Have Mutations in Genes that Increase Cancer Risk
- Behavior Pain Assessment Tool Measures Pain In Patients Who Cannot Communicate Verbally
- Increased 5-Year Survival Rate Seen in NSCLC Subset Treated With Nivolumab
- Novel Test For Multiple Myeloma Uses Microchip, Conventional Blood Sample
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Mammograms (Fact Sheet)
- Tissue Biobank Procurement Consent Should Include Discussion of Confidentiality Risks
- Health Care Expansion Tied to Increased Rates of Surgical Treatment of Thyroid Cancer
- Thyroid Cancer Incidence Increasing Among Younger, Hispanic, African American Populations
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
- Recommendations Against Contralateral Prophylactic Mastectomy Not Tied to Patient Satisfaction
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|